FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
Released Thursday, 25th April 2024
Good episode? Give it some love!
FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
Thursday, 25th April 2024
Good episode? Give it some love!
Rate Episode
Audience & Reach for FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
See a breakdown of Audience & Reach for FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
Unlock Episode Audience & Reach with Podchaser Pro
Brand Safety for FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
See Brand Safety for FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
Unlock Episode Brand Safety with Podchaser Pro
Ad Rate Card of Oncology Brothers: Practice-Changing Cancer Discussions
How much does it cost to advertise on Oncology Brothers: Practice-Changing Cancer Discussions?
PlacementCost
Pre-rollAds played before an episode.
Mid-rollAds played during an episode.
Post-rollAds played after an episode.
Frequently Asked Questions about Oncology Brothers: Practice-Changing Cancer Discussions
Rate
From The Podcast
Oncology Brothers: Practice-Changing Cancer Discussions
The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients.Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format. Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice. Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities.If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at [email protected]Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Episode Tags
Do you host or manage this podcast?
Claim and edit this page to your liking.
,Claim and edit this page to your liking.
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us